User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
Institutional References Quartile Statistics FAQ User Guide Contact us
Institutional Application Application for Journals
Türkçe English
 ASOS INDEKS
 Views 11
Menu
Mendeley
Endnote
Androjen baskılama tedavisinin metabolik yan etkileri: Ürolog neye dikkat etmeli?
2010
Journal:  
Bulletin of Urooncology
Author:  
Abstract:

Androgen deprivation therapy (ADT) is increasingly used for the treatment of recurrent or metastatic prostate cancer. ADT is associated with an increased risk of multiple side effects that may reduce quality of life and even overall survival. ADT increase fat mass, decrease lean body mass and insulin sensitivity. ADT also increase serum levels of triglycerides and cholesterol. Moreover, ADT induced changes may increase the risk of cardiovascular mortality. Urologists should discuss the possible benefits and side effects in detail with patients prior to starting ADT especially in patients with known risk factors for cardiovascular mortality. The aim of this paper is to review the existing literature to understand the metabolic side effects of ADT in patients with prostate cancer.

Keywords:

Citation Owners
Information: There is no ciation to this publication.
Similar Articles
1. Prostat kanserinde kemik metastazlarına yaklaşım algoritması ne olmalıdır ?
2010


  Details
 Download PDF
2. Intermittent Versus Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer: Review
2015


  Details
 Download PDF
3. In which fields intermittent androgen deprivation therapy can be used in 2014?
2014


  Details
 Download PDF
4. A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
2016


  Details
 Download PDF
5. New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
2013


  Details
 Download PDF
6. New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
2013


  Details
 Download PDF
Bulletin of Urooncology

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 112
Cite : 2
2023 Impact : 0.012
Quarter
Basic Field of Health Sciences
Q4
197/222
Details
Bulletin of Urooncology